Lilly Oncology International @LillyOncInt

Channel for the Professional Oncology & Hematology Communities. Follow us for congress news, interviews & insightful updates. Guidelines:https://t.co/uVFdzxpAc6 International Joined May 2022

Tweets

314
Followers

2K
Following

38
Likes

0

Lilly Oncology International @LillyOncInt

3 days ago

Blood Cancer Awareness Month is a time to reflect. What barriers do you face when applying shared decision-making with CLL patients?

0 0 1 11K 0

Lilly Oncology International @LillyOncInt

4 days ago

When #CLL progresses, many carry unasked questions that may stand in the way of shared decisions. As an HCP, you can encourage an open conversation. #WCLLD25 #chroniclymphocyticleukemia #bloodcancer

1 2 8 180 0

Download Image

Lilly Oncology International @LillyOncInt

2 weeks ago

#CLL is a slow-moving blood cancer—but when it progresses, timely action matters.¹ How can we better identify early signs of progression? From subtle lab changes to physical symptoms, recognizing the clues early is key to guiding better care.

0 0 0 139 0

Download Image

Lilly Oncology International @LillyOncInt

2 weeks ago

Clear, compassionate conversations can help transform care. Dr. Marcelo Pitombeira de Lacerda explores how shared decision-making empowers patients with #HematologicalMalignancy—an approach that reflects Lilly’s deep commitment to patient-centered care.

0 0 0 121 0

Download Video

Lilly Oncology International @LillyOncInt

3 weeks ago

High BMI can be an underrecognized factor contributing to poor prognosis in patients with #EarlyBreastCancer. As risk stratification tools evolve, how should body composition be integrated into long-term care strategies and intervention planning?

0 0 0 114 1

Download Image

Lilly Oncology International @LillyOncInt

3 weeks ago

Watch Dr. Scarfò discuss how identifying high-risk features—such as resistance mutations and adverse genetic markers—can help tailor #CLL management strategies. Learn how patient-reported outcomes and preferences further support a more individualized approach. #EHA2025

0 0 0 114 0

Download Video

Lilly Oncology International @LillyOncInt

3 weeks ago

In #CLL, the Binet staging system is widely used to assess disease risk through physical examination of lymph nodes and organs. It groups patients by the number of affected areas—like head/neck and palpable spleen or liver—to help guide informed clinical decision-making.

0 0 0 103 0

Download Image

Lilly Oncology International @LillyOncInt

a month ago

For many with #ChronicLymphocyticLeukemia, diagnosis comes without symptoms—often uncovered when the patient has a routine blood test.

0 0 0 86 0

Download Image

Lilly Oncology International @LillyOncInt

a month ago

In managing #BreastCancer, age is more than a statistic—it can directly impact recurrence risk and long-term outcomes. Could earlier integration of age-based data lead to more precise patient journeys from diagnosis to survivorship? #RiskOfRecurrence

0 0 2 92 0

Download Image

Lilly Oncology International @LillyOncInt

2 months ago

With its unpredictable progression, #MantleCellLymphoma calls for close attention to quality of life. How can assessing HRQoL support #MCL patient-centered care?

0 0 0 101 0

Download Image

Lilly Oncology International @LillyOncInt

2 months ago

The highest risk of first recurrence in patients with #EarlyBreastCancer occurs within the first five years after diagnosis. Could this critical period serve as a window of opportunity in guiding more objective and individualised therapy decisions in the future?

0 1 1 109 1

Download Image

Lilly Oncology International @LillyOncInt

2 months ago

#ChronicLymphocyticLeukemia impacts thousands every year, with 4.2 new cases per 100,000 people in the developed countries. Stay connected for more educational updates about #CLL.

0 1 1 126 0

Download Video

Lilly Oncology International @LillyOncInt

2 months ago

#CLL, or #ChronicLymphocyticLeukemia, is a blood cancer marked by the buildup of abnormal B cells in the bone marrow, blood, spleen, and lymph nodes. As awareness grows, so does the potential for different approaches to managing this complex disease.

0 0 2 167 0

Download Image

Lilly Oncology International @LillyOncInt

2 months ago

Why does risk stratification matter in #EarlyBreastCancer? Identifying patients at high #RiskOfRecurrence early and urgently can refine therapeutic decisions and guide more focused follow-ups.